Keystone Symposia

This meeting took place in 2012

Here are the related meetings in 2020:
The Global Virome in Health and Disease (C1)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Viral Immunity and Host Gene Influence (X6)

Organizer(s) Laurence C. Eisenlohr, Connie C. Bergmann, Stephen J. Turner and Andrea Lynn Cox
March 21—26, 2012
Keystone Resort • Keystone, CO USA
Abstract Deadline: Nov 21, 2011
Late Abstract Deadline: Dec 22, 2011
Scholarship Deadline: Nov 21, 2011
Early Registration Deadline: Jan 20, 2012

Supported by the Directors' Fund

Joint Meeting: HIV Vaccines (X5)

Summary of Meeting:
This meeting will focus on recent advances in viral immunity and host gene influence that have most excited the scientific community. Systems biology approaches are being increasingly applied to the exploration of host-pathogen interactions, including the impact of viral infection on innate and adaptive immunity. Accordingly, the keynote talk will be on this topic. The first full session on the next day will focus on innate immunity, a field that continues to evolve rapidly and hold great interest in the field. In the evening the audience will hear from others who have successfully applied a systems biology approach to examine virus-host interactions. The second day explores adaptive immunity, a topic that historically has been a centerpiece for this meeting, and an area that continues to move forward rapidly. On the third day, the morning session will focus on immune evasion and subversion and will illustrate how formidable the opposition can be and why vaccine development for a number of important human diseases is so challenging. Talks on persistent and chronic viral infections, a topic with clear relevance to a number of human diseases, will be covered in the evening session. The morning session of the final day will cover immune tailoring in non-lymphoid tissues; talks will illustrate how different host responses can and must be, depending upon anatomical location of the infection. The final session will cover the latest advances in the development of vaccines and therapeutics, the traditional ending for this meeting series and a reminder to attendees of the ultimate objectives. Overall, the objective of the Keystone Symposia meeting on Viral Immunity and Host Gene Influence is to accelerate progress in understanding and manipulating anti-viral immunity to improve human health. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on HIV Vaccines, which will share a keynote address and three plenary sessions with this meeting. We anticipate this pairing will facilitate a wider cross-fertilization of ideas and foster innovative collaborations among scientists working in vaccinology and those studying innate immune mechanisms and other viral diseases.

View Meeting Program


Keystone Symposia Future of Science Fund Scholarship Recipients

Nathan P. Croft
University of Melbourne, Australia

William Ince
NIAID, National Institutes of Health, USA

Hassen Kared
A-STAR, Singapore

Christelle Pythoud
Institute of Microbiology, University of Lausanne, Switzerland

Patrick C. Rämer
University of Zürich, Switzerland

Ruth Simmons
University of Oxford, UK

Michael E. Wortzman
University of Toronto, Canada

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Kizzmekia S. Corbett
NIAID, National Institutes of Health, USA

Christopher P. Loo
Oregon Health & Science University, USA

Monica Macal
Five Prime Therapeutics, Inc, USA

National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Michael Davies
Penn State Hershey College of Medicine, USA

Lila Ann Farrington
University of California, San Francisco, USA

James A. Harker
Imperial College London, UK

Daniela C. Kroy
Massachusetts General Hospital and Harvard Medical School, USA

Ryan A. Langlois
University of Minnesota, USA

Chun Li
Ragon Institute of MGH, MIT and Harvard, USA